Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
Jordan Fulcher, Rachel O’Connell, Merryn Voysey, et al.
The Lancet (2015) Vol. 385, Iss. 9976, pp. 1397-1405
Open Access | Times Cited: 1330

Showing 1-25 of 1330 citing articles:

2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
European Heart Journal (2018) Vol. 39, Iss. 33, pp. 3021-3104
Open Access | Times Cited: 8701
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
Borja Ibáñez, Stefan James, Stefan Agewall, et al.
European Heart Journal (2017) Vol. 39, Iss. 2, pp. 119-177
Open Access | Times Cited: 8545
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 111-188
Open Access | Times Cited: 6803
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Juhani Knuuti, William Wijns, Antti Saraste, et al.
European Heart Journal (2019) Vol. 41, Iss. 3, pp. 407-477
Open Access | Times Cited: 5933
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 5427
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4190
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
Atherosclerosis (2019) Vol. 290, pp. 140-205
Open Access | Times Cited: 4150
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino, Peter J Grant, Victor Aboyans, et al.
European Heart Journal (2019) Vol. 41, Iss. 2, pp. 255-323
Open Access | Times Cited: 4088
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano, Ian Graham, Guy De Backer, et al.
European Heart Journal (2016) Vol. 37, Iss. 39, pp. 2999-3058
Open Access | Times Cited: 2845
2018 ESC/ESH Guidelines for the management of arterial hypertension
Bryan Williams, Giuseppe Mancia, Wilko Spiering, et al.
Journal of Hypertension (2018) Vol. 36, Iss. 10, pp. 1953-2041
Open Access | Times Cited: 2558
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Journal of the American College of Cardiology (2018) Vol. 73, Iss. 24, pp. e285-e350
Open Access | Times Cited: 2084
2023 ESC Guidelines for the management of acute coronary syndromes
Robert A. Byrne, Xavier Rosselló, J J Coughlan, et al.
European Heart Journal (2023) Vol. 44, Iss. 38, pp. 3720-3826
Open Access | Times Cited: 1758
Interpretation of the evidence for the efficacy and safety of statin therapy
Rory Collins, Christina Reith, Jonathan Emberson, et al.
The Lancet (2016) Vol. 388, Iss. 10059, pp. 2532-2561
Open Access | Times Cited: 1616
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano, Ian Graham, Guy De Backer, et al.
Atherosclerosis (2016) Vol. 253, pp. 281-344
Open Access | Times Cited: 1539
2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
Todd J. Anderson, Jean Grégoire, Glen J. Pearson, et al.
Canadian Journal of Cardiology (2016) Vol. 32, Iss. 11, pp. 1263-1282
Closed Access | Times Cited: 1089
Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
Aidin Rawshani, Araz Rawshani, Stefan Franzén, et al.
New England Journal of Medicine (2017) Vol. 376, Iss. 15, pp. 1407-1418
Open Access | Times Cited: 1061
Epidemiology of cardiovascular disease in China: current features and implications
Dong Zhao, Jing Liu, Miao Wang, et al.
Nature Reviews Cardiology (2018) Vol. 16, Iss. 4, pp. 203-212
Closed Access | Times Cited: 1021
American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease
Paul S. Jellinger, Yehuda Handelsman, Paul D. Rosenblit, et al.
Endocrine Practice (2017) Vol. 23, pp. 1-87
Closed Access | Times Cited: 982
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Birgit Vogel, Mónica Acevedo, Yolande Appelman, et al.
The Lancet (2021) Vol. 397, Iss. 10292, pp. 2385-2438
Closed Access | Times Cited: 903
European Society of Cardiology: Cardiovascular Disease Statistics 2019
Adam Timmis, Nick Townsend, Chris P Gale, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 12-85
Open Access | Times Cited: 883
Cardiovascular Disease in Women
Mariana García, Sharon L. Mulvagh, C. Noel Bairey Merz, et al.
Circulation Research (2016) Vol. 118, Iss. 8, pp. 1273-1293
Open Access | Times Cited: 855
Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia
Amit V. Khera, Hong‐Hee Won, Gina M. Peloso, et al.
Journal of the American College of Cardiology (2016) Vol. 67, Iss. 22, pp. 2578-2589
Open Access | Times Cited: 828
European Society of Cardiology: cardiovascular disease statistics 2021
Adam Timmis, Panos Vardas, Nick Townsend, et al.
European Heart Journal (2021) Vol. 43, Iss. 8, pp. 716-799
Open Access | Times Cited: 743
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Terry A. Jacobson, Kevin C. Maki, Carl E. Orringer, et al.
Journal of clinical lipidology (2015) Vol. 9, Iss. 6, pp. S1-S122.e1
Open Access | Times Cited: 742
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, et al.
The Lancet (2017) Vol. 391, Iss. 10117, pp. 205-218
Closed Access | Times Cited: 717
Page 1 - Next Page

Scroll to top